Official title   Cerebellar Transcranial Direct Current Stimulation in 
Parkinson's Disease    
NCT number  [STUDY_ID_REMOVED] 
Document date   August 15, 2019  
Prospective subjects will include 10 adults with mild- moderate PD that will be recruited to 
complete five randomly  ordered  cerebellar stimulation sessions (SHAM, unilateral 2 mA, 
unilateral 4 mA, bilateral 2 mA, and bilateral 4 mA),  separated by [CONTACT_2669] 5  days. Each session 
will involve one visit to the Integrative Neurophysiology Laboratory (INPL)  and will last for 
approximately one hour. We expect data collection to last 4- [ADDRESS_245417], the Movement Disorder Society -Unified Parkinson's Disease 
Rating Scale Motor Section (MDSUPDRSIII) will be completed. Then tDCS will be donned and the stimulation period will begin. After 5 minutes of  pre-activity stimulation, gait and balance 
testing will be performed in randomly -ordered blocks of randomized tests  (i.e., block order 
randomized; each test randomized within the block; see below). The gait and balance bloc ks 
are expected to take approximately [ADDRESS_245418] been completed, and the stimulation period 
has ended (25 minutes), the tDCS device will be removed and the MDS -UPDR S III will be 
repeated to check for any acute changes in disease symptoms.   
 
Gait block:  1) the fast [ADDRESS_245419] (30mWT; walk [ADDRESS_245420] as safely possible; 
walking characteristics  and time taken to complete the task are the primary outcomes), 2) a [ADDRESS_245421] (6MWT; walk continuously  between two markers spaced 30 meters apart for 6 
minutes at a brisk pace; total distance walked and walking characteristics are the primary 
outcomes), 3) two trials of the Timed Up and Go test (TUG; stand from a seated position, walk 5 
meters, turn around, sit back down in the chair; time to complete the test is the primary 
outcome).  Subjects will wear six motion sensors (OPAL inertial motion units) on the top of both 
shoes/feet, at both wrists, on the  lower back (5th lumbar spi[INVESTIGATOR_050]), and on the chest/sternum 
during the 30mWT and the 6MWT. The subjects will perform these walks in a cordoned- off 
hallway adjacent to the laboratory.  
 Balance block:  1) stand on a firm surface (directly on a force platform) for 1 minute with eyes 
open (balance characteristics [95% confidence interval of the total 2D area explored, center of 
pressure movement velocity in forward/backward and left/right directions] are the primary 
outcomes), 2) stand on a foam surface (6 cm foam pad  placed on top of force platform) for 1 
minute with eyes open (the same balance characteristics as above are the  primary outcomes).  
 Subjects will be carefully watched and guarded against falling during all of the testing 
procedures. Study personnel  will always be within arm's reach to help the subject recover their 
balance, when necessary.  
 
Active cerebellar tDCS protocol:  A tDCS device (Soterix) will deliver either [ADDRESS_245422] current through two sponge surface electrodes (5cm Ã— 7cm, soaked with 15 mM  NaCl). 
Unilateral cerebellar tDCS will have the anode (positive electrode) placed [ADDRESS_245423] PD -affected side. The cathode (negative electrode) will 
be placed on the ipsilateral buccinator muscle (cheek ). Bilateral cerebellar tDCS will have  both 
electrodes placed [ADDRESS_245424] PD -
affected side and the cathode assigned to the less PD -affected side. Total simulation time will 
be 25 minutes.  
 
SHAM cerebellar tDCS session:  Electrode placement for SHAM will be the same as the 
unilateral cerebellar montage in 50% of subjects (5 subjects) and the bilateral cerebellar 
montage in the other 50% of subjects (5subjects). During  SHAM, the tDCS device automatically  
performs a ramp -up and ramp -down (gradual increase/decrease in intensity)  during the first [ADDRESS_245425] 30 seconds of the SHAM condition. During the intervening time (0:30 - 
24:30),  the stimulation is set to 0 mA.  
 
The stimulation device will be placed in a backpack worn by [CONTACT_205775]. Both subjects and study personnel (except the PI) will be blinded to the 
stimulation condition; the PI [INVESTIGATOR_205774]. All other study personnel  who help administer the gait 
and balance tests will be blind to the stimulation condition. The subjects will be asked to guess 
their stimulation condition at the end of each session. However, they will not be informed of the 
accuracy of  their guesses until they have fully completed study participation (i.e., after the last 
session). We will also ask subjects  to report any stimulation- related sensations (e.g., itching, 
burning, tingling, headache, etc.), and their magnitude (10- point Likert scale), they experienced 
during the session. These will be recorded on the demographic/data collection form (see 
attached).  
 
There will be no long -term follow up.  
 
STATISTICAL ANALYSIS  
Performance on the gait and balance tests will be analyzed using a one -way repeated 
measures ANOVA with five conditions (SHAM, unilateral 2 mA, unilateral 4 mA, bilateral 2 mA, 
bilateral 4 mA) followed by [CONTACT_205776].  
The primary gait outcome measures will be time to complete the 30mWT, distance walked in the 
6MWT, and the  average time to complete the TUG test. Because we hypothesize that tDCS will 
improve the negative effects of gait,  standard gait metrics during the two walk tests,  including 
gait speed, cadence, stride length and time, step length and time, will be assessed with the OPAL motion sensor system.  
The primary balance outcome measures will be 95% confidence interval ellipse (an ellipse that 
contains 95% of the 2D trace of  the center of pressure [COP] movement during the balance 
tests) and COP velocity in the  forward/backward and left/right directions. 